Cargando…
Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers
Introduction. Cardiovascular (CV) diseases are a major cause of death in rheumatoid arthritis (RA) patients. Novel biomarkers [B-type natriuretic peptide (BNP); osteoprotegerin (OPG)/receptor activator of nuclear factor-kappa B ligand (RANKL) ratio; and dickkopf-1 (DKK-1)] have been used in CV risk...
Autores principales: | Bernardes, Miguel, Vieira, Tiago S., Martins, Maria João, Lucas, Raquel, Costa, Lúcia, Pereira, Jorge G., Ventura, Francisco, Martins, Elisabete |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434312/ https://www.ncbi.nlm.nih.gov/pubmed/28553649 http://dx.doi.org/10.1155/2017/6509754 |
Ejemplares similares
-
Diagnostic and Therapeutic Challenge of Metatarsalgia in a Patient With Rheumatoid Arthritis
por: Malta, João N, et al.
Publicado: (2022) -
Portuguese adaptation and validation of a patient-reported experience measure for patients with rheumatoid arthritis: A protocol study
por: Oliveira, Daniela, et al.
Publicado: (2022) -
Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis
por: Giles, Jon T, et al.
Publicado: (2005) -
Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014) -
Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis
por: Figueiredo-Braga, Margarida, et al.
Publicado: (2018)